Day: December 6, 2021

BRENTWOOD, Tenn., Dec. 06, 2021 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative and rehabilitative orthopedic treatments without the use of surgery or opioids, today announces that management will participate at the Benzinga Global Small Cap Conference, which is being held virtually from December 8 – 9, 2021. Chief Executive Officer Jeffrey Ervin will deliver his corporate presentation on Wednesday, December 8, 2021, at 10:50am ET. Investors can also request a one-on-one meeting with Mr. Ervin to be arranged following the conclusion of the conference. Investors can register for the conference here: https://www.benzinga.com/events/small-cap/december-2021-global/ About IMAC Holdings, Inc. IMAC Holdings owns and manages...

Highlights of the third quarter include:Revenue of $180.0 million, an increase of less than one percent compared to $179.4 million in Q3 FY21. Net loss of $5.0 million, compared to net income of $1.8 million in Q3 FY21, with non-GAAP net income of $28.9 million, a decrease of 10% compared to $32.2 million in Q3 FY21. Net loss per diluted share of $0.06, compared to net income per diluted share of $0.02 in Q3 FY21, with non-GAAP net income per diluted share of $0.35, compared to $0.41 in Q3 FY21. Adjusted EBITDA of $61.1 million, the same as in Q3 FY21. 6.2 million HSAs, an increase of 14% compared to Q3 FY21. Total HSA Assets of $16.4 billion, an increase of 32% compared to Q3 FY21. 13.3 million Total Accounts, including both HSAs and complementary CDB accounts, an increase of 6% compared to Q3 FY21. The Company closed its acquisition...

VANCOUVER, British Columbia, Dec. 06, 2021 (GLOBE NEWSWIRE) — Candelaria Mining Corp. (TSX-V: CAND, OTCQX: CDELF) (the “Company”) would like to invite individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentation on VirtualInvestorConferences.com. DATE: December 8, 2021TIME: 7:30AM PST / 10:30AM ESTLINK: https://bit.ly/3d42UQf This will be a live, interactive online event where investors are invited to ask the Company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at www.virtualinvestorconferences.com. ON...

HERZLIYA, Israel, Dec. 06, 2021 (GLOBE NEWSWIRE) — The event time should read: 10:00 a.m. PT/1:00 p.m. ET (instead of 10:45 a.m. PT/1:45 p.m. ET). The updated release reads: Playtika Holding Corp. (NASDAQ:PLTK), a leading mobile gaming company, today announced that the company will participate in the following upcoming virtual investor conference:Wedbush Winter Games Conference. Craig Abrahams, Playtika’s President and Chief Financial Officer, will virtually present a fireside chat on December 8, 2021 at 10:00 a.m. PT/1:00 p.m. ET.A live webcast of the presentation will be available on Playtika’s Investor Relations page at https://investors.playtika.com/. A replay of the presentation will be available on the company’s Investor Relations page. About PlaytikaPlaytika Holding Corp. is a leading mobile gaming company and monetization...

NEWPORT NEWS, Va., Dec. 06, 2021 (GLOBE NEWSWIRE) — Huntington Ingalls Industries’ (NYSE:HII) Ingalls Shipbuilding division today officially started fabrication of the Arleigh Burke-class (DDG 51) destroyer George M. Neal (DDG 131). “Start of fabrication is our first opportunity to formally celebrate and reflect on our contributions as shipbuilders,” Ingalls Shipbuilding President Kari Wilkinson said. “We are very proud of what we do here for the country and endeavor to do our part in building and activating what will be the newest Flight III destroyer.” Ingalls has delivered 33 Arleigh Burke-class destroyers to the Navy. Other destroyers currently under construction include Lenah Sutcliffe Higbee (DDG 123), Jack H. Lucas (DDG 125), Ted Stevens (DDG 128) and Jeremiah Denton (DDG 129). A photo accompanying this release is available...

New York, NY, and Tel Aviv, ISRAEL, Dec. 06, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Todos Medical will be presenting at the upcoming Emerging Growth Conference to be held on December 8, 2021. The following are details for the conference: Event: Emerging Growth Conference Date: December 8, 2021 Location: On-Line Time: Todos Medical Presentation at 3:00pm Eastern Standard Time This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s CEO, Gerald Commissiong, in real time. Please register here to ensure you are able to attend the conference and receive any updates that are released: https://goto.webcasts.com/starthere.jsp?ei=1512636&tp_key=b542885e5a&sti=tomdf. If...

REGULATED INFORMATION – Paris, 01/12/2021 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Article 223-16 of the AMF General Regulation  Date     Shares     Voting rights  Theoretical (1)   Exercisable (2)  30 November 2021 382,486,968 510,342,794 507,782,794(1)  In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all the shares to which voting rights are attached, including shares for which voting rights have been suspended. (2)  For information purposes only, this number has been calculated net of the shares for which voting rights have been suspended. The information is also available in the “Regulated Information” section of the Bouygues website. BOUYGUES SAA French Société Anonyme with share capital of €380,759,842Registered office: 32,...

Sorrento has received orders from its logistics partner and a large diagnostic laboratory client for official commercial launch of COVISTIX™ COVID-19 Virus Rapid Antigen Detection Test in Brazil.SAN DIEGO, Dec. 06, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today that initial loading orders have been processed and scheduled for delivery later this year. The initial shipment will establish an in-country safety stock to manage just in time ongoing deliveries to local clients. In addition to the loading order, Sorrento’s local distribution partner has received an order from a large diagnostic laboratory in Brazil. The laboratory has a central processing unit and collaborates with about 2,000 other smaller units across the country. COVISTIX tests will be delivered in successive shipments...